IID 2018 update: context-specific physical protein-protein interactions in human, model organisms and domesticated species.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
08 01 2019
Historique:
received: 15 09 2018
accepted: 28 10 2018
pubmed: 9 11 2018
medline: 19 5 2020
entrez: 9 11 2018
Statut: ppublish

Résumé

Knowing the set of physical protein-protein interactions (PPIs) that occur in a particular context-a tissue, disease, or other condition-can provide valuable insights into key research questions. However, while the number of identified human PPIs is expanding rapidly, context information remains limited, and for most non-human species context-specific networks are completely unavailable. The Integrated Interactions Database (IID) provides one of the most comprehensive sets of context-specific human PPI networks, including networks for 133 tissues, 91 disease conditions, and many other contexts. Importantly, it also provides context-specific networks for 17 non-human species including model organisms and domesticated animals. These species are vitally important for drug discovery and agriculture. IID integrates interactions from multiple databases and datasets. It comprises over 4.8 million PPIs annotated with several types of context: tissues, subcellular localizations, diseases, and druggability information (the latter three are new annotations not available in the previous version). This update increases the number of species from 6 to 18, the number of PPIs from ∼1.5 million to ∼4.8 million, and the number of tissues from 30 to 133. IID also now supports topology and enrichment analyses of returned networks. IID is available at http://ophid.utoronto.ca/iid.

Identifiants

pubmed: 30407591
pii: 5165345
doi: 10.1093/nar/gky1037
pmc: PMC6323934
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

D581-D589

Références

Nat Genet. 2000 May;25(1):25-9
pubmed: 10802651
Nucleic Acids Res. 2004 Jan 1;32(Database issue):D267-70
pubmed: 14681409
Nucleic Acids Res. 2004 Jan 1;32(Database issue):D449-51
pubmed: 14681454
Bioinformatics. 2004 Feb 12;20(3):307-15
pubmed: 14960456
Nat Biotechnol. 2005 Aug;23(8):951-9
pubmed: 16082366
PLoS Genet. 2006 Jun 2;2(6):e88
pubmed: 16751849
Nat Rev Drug Discov. 2006 Oct;5(10):821-34
pubmed: 17016423
Genome Biol. 2006;7(11):120
pubmed: 17147767
Genome Biol. 2007;8(5):R95
pubmed: 17535438
Proc Natl Acad Sci U S A. 2008 May 13;105(19):6959-64
pubmed: 18474861
Genome Biol. 2008;9 Suppl 1:S7
pubmed: 18613951
Nucleic Acids Res. 2009 Jan;37(Database issue):D767-72
pubmed: 18988627
Nat Methods. 2009 Jan;6(1):83-90
pubmed: 19060904
Mol Syst Biol. 2009;5:260
pubmed: 19357639
Bioinformatics. 2010 Apr 15;26(8):1057-63
pubmed: 20185403
Database (Oxford). 2010 Oct 12;2010:baq023
pubmed: 20940177
Genome Res. 2011 Jul;21(7):1109-21
pubmed: 21536720
Mol Cell Proteomics. 2011 Nov;10(11):M111.010629
pubmed: 21836163
EURASIP J Bioinform Syst Biol. 2011 Aug 04;2011(1):5
pubmed: 21970702
Nucleic Acids Res. 2012 Jan;40(Database issue):D857-61
pubmed: 22096227
J Clin Bioinforma. 2012 Jan 13;2(1):1
pubmed: 22239822
Proteomics. 2012 May;12(10):1687-96
pubmed: 22589215
BMC Syst Biol. 2012 Jul 30;6:92
pubmed: 22846459
Ther Adv Musculoskelet Dis. 2010 Feb;2(1):17-28
pubmed: 22870434
Nature. 2012 Sep 20;489(7416):391-399
pubmed: 22996553
Nature. 2012 Oct 25;490(7421):556-60
pubmed: 23023127
PLoS Comput Biol. 2012;8(9):e1002690
pubmed: 23028288
PLoS Comput Biol. 2012;8(9):e1002694
pubmed: 23028291
Nucleic Acids Res. 2013 Jan;41(Database issue):D1228-33
pubmed: 23180781
Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5
pubmed: 23193258
PLoS One. 2013 Sep 03;8(9):e73074
pubmed: 24019896
Nucleic Acids Res. 2014 Jan;42(Database issue):D358-63
pubmed: 24234451
Nucleic Acids Res. 2015 Jan;43(Database issue):D485-93
pubmed: 25348397
Nucleic Acids Res. 2015 Jan;43(Database issue):D1071-8
pubmed: 25348409
Nat Methods. 2015 Jan;12(1):79-84
pubmed: 25402006
Neuron. 2014 Nov 5;84(3):546-53
pubmed: 25442933
Nat Genet. 2015 Jun;47(6):569-76
pubmed: 25915600
Nucleic Acids Res. 2015 Jul 1;43(W1):W258-63
pubmed: 25990735
Front Genet. 2015 Aug 04;6:260
pubmed: 26300911
Bioinformatics. 2016 Jan 15;32(2):309-11
pubmed: 26415722
Sci Rep. 2015 Nov 30;5:17417
pubmed: 26615774
Mol Syst Biol. 2015 Dec 17;11(12):848
pubmed: 26681426
Nat Commun. 2016 Feb 01;7:10331
pubmed: 26831545
Nucleic Acids Res. 2016 Jul 8;44(W1):W529-35
pubmed: 27131791
Sci Signal. 2016 May 10;9(427):eg7
pubmed: 27165778
BMC Bioinformatics. 2016 Jul 25;17 Suppl 7:229
pubmed: 27454775
Nucleic Acids Res. 2017 Jan 4;45(D1):D408-D414
pubmed: 27794551
Nucleic Acids Res. 2017 Jan 4;45(D1):D331-D338
pubmed: 27899567
Nucleic Acids Res. 2017 Jan 4;45(D1):D427-D431
pubmed: 27899616
Nucleic Acids Res. 2017 Jan 4;45(D1):D158-D169
pubmed: 27899622
Nucleic Acids Res. 2017 Jan 4;45(D1):D362-D368
pubmed: 27924014
Nucleic Acids Res. 2017 Jan 4;45(D1):D833-D839
pubmed: 27924018
Nucleic Acids Res. 2017 Jan 4;45(D1):D369-D379
pubmed: 27980099
Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082
pubmed: 29126136
Nucleic Acids Res. 2018 Jan 4;46(D1):D754-D761
pubmed: 29155950
Nucleic Acids Res. 2018 Jan 4;46(D1):D601-D607
pubmed: 29165593

Auteurs

Max Kotlyar (M)

Krembil Research Institute, University Health Network, Toronto, ON M5T 0S8, Canada.

Chiara Pastrello (C)

Krembil Research Institute, University Health Network, Toronto, ON M5T 0S8, Canada.

Zara Malik (Z)

Krembil Research Institute, University Health Network, Toronto, ON M5T 0S8, Canada.

Igor Jurisica (I)

Krembil Research Institute, University Health Network, Toronto, ON M5T 0S8, Canada.
Departments of Medical Biophysics and Computer Science, University of Toronto, Toronto, ON M5S 1A4, Canada.
Institute of Neuroimmunology, Slovak Academy of Sciences, Bratislava, Slovakia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH